Suspended Wyeth trial to resume in India
This article was originally published in Scrip
Executive Summary
Wyeth has resumed a previously suspended Indian study for its pneumococcal conjugate vaccine, after implementing certain "suggestions" recommended by the Drugs Controller General of India (DCGI). The regulator had suspended the trials last year following the death of an infant.